Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 3

NCT01976923

Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

The purpose of this is study is to assess the efficacy of pre-operative intravitreal bevacizumab (IVB) (Genentech, South San Francisco CA) in improving visual a…

Saudi Arabia224 participantsStarted 2013-11

Treatment: Intravitreal bevacizumab, Small-gauge pars plana vitrectomy

CompletedPhase 1

NCT01487070

A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy…

Primary objective of this trial will be to evaluate the safety and efficacy of intravitreal injections of Macugen (pegaptanib sodium) when given at least 7-14 d…

United States5 participantsStarted 2011-04

Treatment: Macugen (Pegaptanib Sodium)